Compare NICE & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NICE | BCPC |
|---|---|---|
| Founded | 1986 | 1967 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.3B |
| IPO Year | 1999 | 1995 |
| Metric | NICE | BCPC |
|---|---|---|
| Price | $91.60 | $169.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 3 |
| Target Price | $127.54 | ★ $213.50 |
| AVG Volume (30 Days) | ★ 569.0K | 242.3K |
| Earning Date | 11-04-2026 | 10-23-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 4.09 |
| Revenue | N/A | ★ $799,023,000.00 |
| Revenue This Year | $7.91 | $9.17 |
| Revenue Next Year | $7.78 | $5.91 |
| P/E Ratio | ★ $11.21 | $41.93 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $83.10 | $147.18 |
| 52 Week High | $135.55 | $186.15 |
| Indicator | NICE | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 27.87 | 44.71 |
| Support Level | $86.27 | $160.38 |
| Resistance Level | $104.84 | $176.54 |
| Average True Range (ATR) | 3.97 | 4.11 |
| MACD | -1.55 | -0.64 |
| Stochastic Oscillator | 10.68 | 16.21 |
Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.